BeiGene and Mustang nail down special FDA status for top drugs; Roche bags added coverage for Hemlibra
→ BeiGene $BGNE is getting a boost in its drive to field a rival to Imbruvica. The FDA has offered an accelerated review to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
